Unclassified renal cell carcinoma: An analysis of 85 cases

BJU International

Volumn 100, Issue 4, 2007, Pages 802-808

  Karakiewicz, Pierre I ^a   Hutterer, Georg C ^a,h   Trinh, Quoc Dien ^a   Pantuck, Allan J ^b   Klatte, Tobias ^b   Lam, John S ^b   Guille, Francois ^c   De La Taille, Alexandre ^d   Novara, Giacomo ^e   Tostain, Jacques ^f   Cindolo, Luca ^g   Ficarra, Vincenzo ^e   Schips, Luigi ^h   Zigeuner, Richard ^h   Mulders, Peter F ⁱ   Chautard, Denis ^j   Lechevallier, Eric ^k   Valeri, Antoine ^k   Descotes, Jean Luc ^k   Lang, Herve ^k   Soulie, Michel ^l   Ferriere, Jean Marie ^m   Pfister, Christian ⁿ   Mejean, Arnaud ^k   Belldegrun, Arie S ^b   Patard, Jean Jacques ^c,k   more..

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RENNES UNIVERSITY HOSPITAL   (France)

^d HENRI MONDOR HOSPITAL   (France)

^e UNIVERSITY OF PADOVA   (Italy)

^f UNIVERSITÉ JEAN MONNET   (France)

^g G RUMMO HOSPITAL   (Italy)

^h MEDICAL UNIVERSITY OF GRAZ   (Austria)

ⁱ RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^j ANGERS UNIVERSITY HOSPITAL   (France)

^k Departments of Urology   (France)

^l CHU RANGUEIL   (France)

^m BORDEAUX UNIVERSITY HOSPITAL   (France)

ⁿ HÔPITAL CHARLES NICOLLE   (France)

more..

Author keywords

Histology; Kidney; Survival; Unclassified renal cell carcinoma

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GRADING; CANCER MORTALITY; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RARE DISEASE; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CHILD; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; NEPHRECTOMY; REGRESSION ANALYSIS; SURVIVAL ANALYSIS;

EID: 34548381830     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.07148.x     Document Type: Article

References (13)

1. Greene FL. American Joint Committee on Cancer. American Cancer Society. AJCC Cancer Staging Manual, 6th edn. New York : Springer, 2002
2. Zisman A, Chao DH, Pantuck AJ et al. Unclassified renal cell carcinoma. clinical features and prognostic impact of a new histological subtype. J Urol 2002 168 : 950 5
3. Kovacs G, Akhtar M, Beckwith BJ et al. The Heidelberg classification of renal cell tumours. J Pathol 1997 183 : 131 3
4. Ljungberg B, Alamdari FI, Stenling R, Roos G. Prognostic significance of the Heidelberg classification of renal cell carcinoma. Eur Urol 1999 36 : 565 9
5. Amin MB, Amin MB, Tamboli P et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 2002 26 : 281 91
6. Ficarra V, Schips L, Guille F et al. Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma. Cancer 2005 104 : 968 74
7. Motzer RJ, Bacik J, Mariani T, Russo P, Mazumdar M, Reuter V. Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. J Clin Oncol 2002 20 : 2376 81
8. Karakiewicz PI, Briganti A, Chun FK et al. Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol 2007 25 : 1316 22
9. Pizzocaro G, Piva L, Colavita M et al. Interferon adjuvant to radical nephrectomy in Robson stages II and III renal cell carcinoma: a multicentric randomized study. J Clin Oncol 2001 19 : 425 31
10. Messing EM, Manola J, Wilding G et al. Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial. J Clin Oncol 2003 21 : 1214 22
11. Clark JI, Atkins MB, Urba WJ et al. Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial. J Clin Oncol 2003 21 : 3133 40
12. Atzpodien J, Schmitt E, Gertenbach U et al. Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). Br J Cancer 2005 92 : 843 6
13. Kirkali Z. Are we really making an advance in the treatment of metastatic renal cell carcinoma? Eur Urol 2006 49 : 604 5